Davide Calebiro Selected Research

Adrenocortical Adenoma (Disease, Conn's)

1/2021	Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?
1/2021	PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation.
1/2019	Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
1/2019	Cushing's syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity.
1/2017	Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas.
3/2016	Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
10/2015	cAMP signaling in cortisol-producing adrenal adenoma.
12/2014	PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davide Calebiro Research Topics

Disease

12	Cushing Syndrome 01/2021 - 03/2014
10	Neoplasms (Cancer) 01/2021 - 01/2011
9	Adenoma (Adenomas) 01/2021 - 03/2014
8	Adrenocortical Adenoma (Disease, Conn's) 01/2021 - 12/2014
6	Hyperplasia 01/2021 - 03/2014
2	Pain (Aches) 01/2020 - 01/2020
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 01/2018
2	Thyroid Dysgenesis (Thyroid Agenesis) 11/2012 - 06/2010
1	Heart Failure 02/2021
1	Carney Complex 11/2020
1	Acromegaly 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Acth-Independent Macronodular Adrenal Hyperplasia 11/2019
1	Pituitary ACTH Hypersecretion 11/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Obesity 01/2019
1	ACTH-Secreting Pituitary Adenoma 03/2016
1	Hyperthyroidism 01/2016
1	Endocrine System Diseases (Endocrine Diseases) 01/2016
1	Graves Disease (Basedow Disease) 01/2016
1	Carcinogenesis 01/2016
1	Hyperaldosteronism (Conn Syndrome) 01/2016
1	Adrenocortical Carcinoma 10/2014
1	Pseudohypoparathyroidism 12/2006

Drug/Important Bio-Agent (IBA)

16	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021 - 01/2011
15	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 03/2014
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2016
3	Hormones (Hormone)IBA 02/2021 - 01/2016
2	ORALIT (ORS)IBA 01/2020 - 01/2020
2	FilaminsIBA 01/2020 - 01/2018
2	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 01/2020
2	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2019 - 03/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2021
1	NucleotidesIBA 01/2021
1	EnzymesIBA 11/2020
1	Growth Hormone (Somatotropin)IBA 01/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020
1	somatostatin receptor 2IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	LigandsIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	AldosteroneIBA 01/2016
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2016
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2016
1	CateninsIBA 01/2016
1	AndrogensIBA 10/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2014
1	Biological ProductsIBA 12/2012
1	Messenger RNA (mRNA)IBA 11/2012
1	8-chloro-cyclic adenosine monophosphateIBA 01/2011
1	Cyclic AMP (AMP, Cyclic)IBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 06/2010
1	GTP-Binding Protein alpha SubunitsIBA 12/2006

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2016
1	Adrenalectomy 01/2016